Hualan Biological Engineering saw no growth in patent filings in April and highest growth of 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Hualan Biological Engineering’s patent filings and grants. Buy the databook here.
Hualan Biological Engineering has been focused on protecting inventions in China(CN) with 16 publications in Q2 2024
The China(CN) Patent Office dominates the patent grants with nearly 100% of grants. The China(CN) patent Office are among the top ten patent offices where Hualan Biological Engineering is filings its patents. Among the top granted patent authorities, Hualan Biological Engineering has 100% of its grants in China(CN).
GSK and EpiVax could be the strongest competitors for Hualan Biological Engineering
Patents related to climate change and circular economy lead Hualan Biological Engineering's portfolio
Hualan Biological Engineering has the highest number of patents in climate change followed by, circular economy and circular plastic economy. For climate change no patents were filed and 40% of patents were granted in Q2 2024.
Packaging related patents lead Hualan Biological Engineering portfolio followed by manufacturing/industrial, and recycling
Hualan Biological Engineering has highest number of patents in packaging followed by manufacturing/industrial, recycling.
For comprehensive analysis of Hualan Biological Engineering's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.